HealthSupervisionforChildrenWithNeurofibromatosis368PEDIATRICSVol.96No.2August1995CommitteeonGeneticsThissetofguidelinesisdesignedtoassistthepediatricianincaringforthechildinwhomthediagnosisofneurofibromatosishasbeenmade.Al-thoughthepediatrician’sfirstcontactwiththechildisusuallyduringinfancy,occasionallythepregnantwomanwhohasbeengiventheprenataldiagnosisofneurofibromatosiswillbereferredforadvice.There-fore,theseguidelinesofferadviceforthissituationaswell.Atleasttwodistincttypesarerecognized-neurofi-bromatosis1,orNF-1(previouslyknownasvonReck-linghausendiseaseorgeneralizedneurofibromatosis),andneurofibrornatosis2,orNF-2(previouslyknownasbilateralacousticneurofibromatosis).ThisdiscussionaddressesonlyissuesconcerningthediagnosisandmanagementofNF-1.18NeurofibrornatosisIisaprogressive,multisystemdisorderaffectingaboutIin3,000individuals.9ANationalInstitutesofHealth(NIH)ConsensusDe-velopmentConference’#{176}regardingNF-1demarcatedsevenfeatures,ofwhichtwoormorearerequiredtoestablishfirmlythediagnosisofNF-1:I.Sixormorecafe-au-laitspots(CLS)ormacules,greaterthanorequalto5mmindiameterinprepubertalpatientsand15mmindiameterinpostpubertalpatients;2.Twoormoreneurofibromataofanytype,oroneplexiformneurofibroma;3.Frecklingintheaxillaryoringuinalregion;4.Opticglioma;5.TwoormoreLischnodules(irishamartomas);6.Adistinctiveosseouslesionsuchassphenoiddys-plasiaorcorticalthinningoflongbones,withorwithoutpseudarthrosis;or7.Afirst-degreerelative(parent,sibling,orchild)withNF-1accordingtotheprecedingcriteria.Diagnosisinnonfamilialpediatriccasesmaybedifficultbecausecertainclinicalfeaturesareage-de-Therecommendationsinthisstatementdonotindicateanexclusivecourseoftreatmentorproceduretobefollowedforchildrenwithneurofibroma-tosis,butaremeanttosupplementanticipatoryguidelinesavailablefortreatingthenormalchildprovidedintheAAPpublication,“GuidelinesforHealthSupervision.”Theyareintendedtoassistthepediatricianinhelpingchildrenwithneurofibromatosistoparticipatefullyinlife.Diagnosisandtreatmentofneurofibromatosisareconstantlychanging.Therefore,pedia-triciansareencouragedtoviewtheseguidelinesinlightofevolvingscien-tificinformation.Clinicalgeneticists,particularlythoseassociatedwithNFspecialtyclinics,andotherspecialistsmaybeavaluableresourceforthepodiatricianseekingadditionalinformationorconsultation.Variations,tak-ingintoaccountindividualcircumstances,maybeappropriate.PEDIATRICS(ISSN00314005).Copyright©1995bytheAmericanAcad-emyofPediatrics.pendent.Forthesamereason,theseverityofNF-1inlaterlifemaybeunderestimatedinanaffectedchild.CongenitallesionsincludeCLSand,lesscorn-monly,axillaryfrecklingandneurofibromata.Someaffectedchildrenhavenocharacteristiclesionsatbirth.CLStendtoincreaseinsizeandnumberthroughoutearlychildhood.Laterinchildhood,neu-rofibromatabecomeevidentasskinnodulesortagslocatedincutaneousorsubcutaneoustissues,orassubcutaneousmassesinvolvingdeeptissues(plexi-formneurofibromas).Skinoverlyingplexiformneu-rofibromassometimesshowshyperpigmentationandhypertrichosis.Neurofibromatacanbefoundinallorgansystems,givingrisetospecificsymptomsdependingonsize,location,anddegreeofencroach-mentonsurroundingtissues.Markedgrowthoftheselesionscanoccuranytimeinchildhoodbutparticularlyinadolescenceandpregnancy.COMPLICATIONSThecomplicationsofNF-1resultfromdirectin-volvementofmultiplesystemsbyneurofibromata,anincreasedriskformalignancy(mostlyfibrosarco-masbutalsoothermalignancies,includingleuke-mia),’1andpoorlyunderstoodassociationssuchasmentalretardation,shortstature,andneurologicandvascularchangesunassociatedwithneurofibrornata.Sarcomatouschangesmayoccurinneurofibrornata,characteristicallyindeeplesions.Pain,rapidgrowth,andnewlocalizingneurologicfindingssometimessuggestmalignantchanges,whichareotherwisedifficulttodetect.Amongtheunusualbutmoreseriouscomplica-tionsofwhichthefamilyshouldbeawareareopticgliomas(leadingtoblindness)andotherbrainandnervetumors,hypertension,kyphosisand/orscoli-osis(leadingtodiminishedpulmonaryfunction),gastrointestinalbleedingsecondarytogastrointesti-nalneurofibromata,facialdisfigurementfromneu-rofibromata,andpseudarthroses.Deathmayresultfromsomeofthesecomplications.Forunknownreasons,NF-1isassociatedwithanincreasedincidenceofmentalretardation,al-thoughitisusuallynotsevere.Learningproblems,speechretardationofanonspecificnature,hyper-activity,seizures,andEEGchangesarealsocorn-monlyreported.12”3Ifseizuresarepresent,intra-cranialtumorsmustbeexcluded,althoughoftennospecificetiologyfortheseizuredisorderisfound.PersonswithNF-1tendtoshowsubtleneurologicabnormalitiesinvolvingfinecoordina-tion,balance,andgait.ThereportedincidenceofcomplicationsinNF-1by guest on May 2, 2017Downloaded from AMERICANACADEMYOFPEDIATRICS369variesfromstudytostudymostlybecauseofbi-asedpatientselectionbyageandspecialtyreferral,butalsobecauseofinconsistentdiagnosticcriteriaandvariableutilizationofimagingtechniques.Generallycomplicationsareoverestimatedbe-causemoststudiesinvolvepatientsinhospitalsorreferralclinics.’4AboutonethirdofpatientswithNF-1showseriouscomplications,andaboutonehalfaremildlyaffected.However,becauseoftheextremedegreeofvariabilityevenwithinafamily,itisnotpossibletopredicttheclinicalfeaturesinaspecificperson.GENETICSTransmissionofNF-1isbyanautosomaldomi-nantmodeofinheritance.Inabouthalfofthepa-tients,theconditionisduetoanewmutation.Insuchinstancestheparents(bothphenotypicallynor-malinregardtoNF-1)arenotatincreasedriskcomparedwiththenormalpopulationtohavean-otherchildaffectedwiththisdisorder.However,thepersonswithnewmutationsareat50%risktotrans-mitthegenetotheiroffspring.ThemutantNF-1genehasahighpenetrancerate,andonlyrarelydoesapersonknowntohavethismutationshownoclinicalmanifestations.TheNF-1genehasbeenlocalizedtochromosome17atbandq11.2.1(cid:1)’7Neurofibromin,theproteinproductofthenonmutatedgenelocus,isthoughttoactasatumorsuppressorundernormalconditionsbydown-regulatinganothercellproteinthaten-hancescellgrowthandproliferation.18Pointmuta-tionsanddeletionshavebeenidentifiedwithintheNF-1gene,givingrisetodiminishedfunctionofneurofibromininaffectedpersons.DNAanalysisfortheneurofibromatosismutationisnotyetcommer-ciallyavailable,butlinkagestudiesusingDNAmarkershavebeenaccuratein95%to99%ofthepatientsstudied.19Linkageanalysis,however,re-quiresstudyofseveralfamilymembersandisnotapplicabletoallpatients.CLINICALMANAGEMENTThemultiorganoccurrenceofneurofibromasandtheircomplicationsoftenrequirescarefromavarietyofmedicalandsurgicalspecialists.Thepediatricianshouldcoordinatesuchcare.PatientswithmorethanminimalmanifestationsofNF-1maybenefitfromreferraltoamultidisciplinaryneurofibromatosis(NF)clinicforprimaryorspecialtycare.SuchclinicsareavaluableconsultationresourceforpediatricianscaringforpatientswithNF-1.Treatmentisaimedatthecomplicationsastheyoccur.Someoftheproblems,suchasrenalarterystenosis,ifdetectedearly,canbemanagedsuccess-fully.Enlargingtumorscansometimesbeman-agedbyobservationandsurgery.However,surgi-calremovalofaneurofibromacompromisinganessentialorgansystemmaynotbepossiblebe-causeofaninaccessiblesiteorinfiltrationintosurroundingtissue.Ifmalignancies(includingleu-kemia)develop,treatmentisthesameasforchil-drenwithoutNF-1.InthemedicalsupervisionofachildwithNF-1,anumberofareasrequireongoingassessmentandperiodicreviewthroughoutlife(Table),includingthefollowing:I.Evaluatethechildfornewneurofibromasandprogressionoflesions.Examinetheskincarefullyforsignsofplexiformneurofibromasthatmayimpingeonorinfiltrateunderlyingstructures.2.Checkthechild’sbloodpressure.Becauserenaldisease(particularlyrenalarterystenosis),aorticstenosis,pheochromocytomas(morecommoninadults)andadrenaltumorsmayoccur,regularandcarefulbloodpressuremeasurementsareimportant.Avarietyofvascularhypertrophiclesionsmaybefound.3.Evaluateneurodevelopmentalprogress.4.Evaluatethechildforskeletalchanges.Lookforscoliosis,vertebralangulation,andlimbabnor-malities.Sometimeslocalizedhypertrophyofaleg,arm,orotherpartofthebodyresultsfromplexiformneurofibromata.5.Ifanycomplicationsoccurorifneurocutaneouslesionsappeartoberapidlyadvancing,refertotheappropriatespecialist.6.RecommendavailableresourcesforpatientswithNF-1(eg,NFclinics,supportgroups,andindivid-ualNF-1families).Supplybooksandpamphlets(obtainablefromtheNationalNFFoundation).TheNationalNFFoundationcanalsoprovidefurtherinformationandcliniclocations.Thead-dressofthisorganizationappearsintheAcknowl-edgmentssection.THEPRENATALVISITAttimesthepediatricianmaybecalledontocoun-selafamilywhenoneoftheparents-to-beisaffectedandthefetushasbeendiagnosedtohaveNF-1byDNAstudies.Inthissituation,thefamilymostlikelyalreadyhasbeencounseledaboutthedisorderanditsinheritancepattern.However,thepediatricianmaybecalledupontoreviewtheinformationandtoassistthefamilyinthedecision-makingprocess.Asappropriate,thepediatricianmaydiscussthefollow-ingissueswiththefamily:1.Reviewtheprenataldiagnosis.2.Explainthemechanismforoccurrenceofthedis-orderinthefetusandtherecurrencerate.3.Reviewtheprognosis,manifestations,variability,andprogressivenatureofthedisorder.4.Reviewthetreatmentsandinterventionsthatarecurrentlyavailable.Thisdiscussionshouldin-dudetheefficacy,complications,sideeffects,andcostorotherburdensofthesetreatments.5.Discusstheoptionsavailabletothefamilyformanagementandrearingofthechild.Incasesofearlyprenataldiagnosis,thismayincludediscus-sionofpregnancytermination,aswellascontin-uationofthepregnancyandrearingthechildathome,adoption,etc.6.Whenappropriate,considerreferringtoaclinicalgeneticistforamoreextendeddiscussionofdin-icalfindings,recurrencerates,futurereproductiveoptions,andevaluationoftherisksofdiseaseforotherfamilymembers.by guest on May 2, 2017Downloaded from TABLE.HealthSupervisionGuidelinesforChildrenWithNeurofibromatosis*370HEALTHSUPERVISIONFORCHILDRENWITHNEUROFIBROMATOSISPrenatalInfancyImo-iyEarlyChildhood1-5yLateChildhood5-13yAdolescence13-21yNeonatal24691215182434Annual’Annual1momomomomomomomoyr’yr(cid:1)DiagnosisDNAanalysis#{149}PhenotypereviewS#{149}Geneticcounseling#{149}#{149}4ReproductiveOptionsforParentsAdoption/termination#{149}Futurereproductiveplanning#{149}#{149}#{149}AnticipatoryGuidanceFamilysupport#{149}#{149}#{149}#{149}S#{149}#{149}#{149}#{149}#{149}#{149}#{149}#{149}Supportgroups#{149}#{149}#{149}#{149}Long-termplanning#{149}#{149}#{149}44Sexualandreproductiveissues#{149}MedicalEvaluationandTreatment5Growth0000000000000Bloodpressure0000000000000Skinexamination0000000000000Boneexamination/scoliosis0000000000000Neurologicalexamination0000000000000Visionscreening5/05/05/05/05/0S/Or’55S/0(cid:1)S/Os5/065/(cid:1)6S/OsHearingscreeningSSSSSS/OhSSSSS/OsS/0S/OSexualmaturation00DiagnosticImagingExaminations5PsychosocialEvaluationDevelopmentandbehavior5/05/05/05/05/05/05/05/05/05/0S/Os5/05/0Pre-schoolprogramSSSchoolplacement/performanceS/0S/OPsychological/socialadjustmentSSSSSSSSIntrafamilyrelationshipsSSSSSSSSSS*AssurecompliancewiththeAmericanAcademyofPediatrics“RecommendationsforPreventivePediatricHealthCare.”.=tobeperformed;S=subjective,byhistory;0=objective,byastandardtestingmethod.I=Advisesemi-annualvisits,asindicated.25e-(cid:1)discussion.3=Orattimeofdiagnosis.4=Onceinthistimeperiod.5=Asneededforsignificantabnormalitiesand/ornewsigns.6=Refertospecialist.7.InformthemthatinmanypartsofthecountrytherearespecialtyNFclinicsthatareavailableforguidance,therapy,andconsultation.HEALTHSUPERVISIONFROMBIRTHTO1MONTH-NEWBORNSExaminationI.Confirmthediagnosisbythepresenceofcutane-ousmanifestations.UseofaWood’slampmaybehelpfulinidentifyingCLS.Axillaryfrecklingissometimespresentatbirth.2.BeawarethatnormalexaminationresultsdonotexcludeNF-1.3.Allfirst-degreerelativesshouldbeadvisedtohaveaphysicalexamination,includingaslitlampexaminationoftheirisesforLischnodules,whicharefoundin>90%ofadultswiththisdisorderbutareuncommoninchildrenunder3yearsofage.4.SomespecialistsadviseaninitialimagingstudyforopticgliomawhenthediagnosisofNF-1ismade.”2#{176}TheNIHConsensusDevelopmentCon-ference’#{176}didnotrecommendcomputedtomogra-phyormagneticresonanceirnagingstudiesforasymptomaticpatientswithNF-1,however,andgenerallyrecommendedspecialstudiesonlywhenclinicallyindicated.AnticipatoryGuidance1.ReviewthenaturalhistoryandgeneticsofNF-1.2.Advisetheparentstoreportanyunusualornewsymptoms.3.Stresstheneedforregularlyscheduledvisits,in-cludingcarefulneurologicandbloodpressureevaluations.HEALTHSUPERVISIONFROM1MONTHTO1YEAR-INFANCYExamination1.Comparetheinfant’sgrowthanddevelopmentwithfiguresongrowthcharts.Asagroup,chil-drenwithNF-1areshorterthanaveragebuthavelargerheads.2.ExaminethepatientforthepresenceofCLS.In-formthefamilythatnewonesmayappearandby guest on May 2, 2017Downloaded from AnticipatoryGuidanceappropriatespecialists.AMERICANACADEMYOFPEDIATRICS371preexistingCLSoftenincreaseinsize.ReassurethefamilythatCLShavenoclinicalsignificance.3.Checkforproptosis,arapidlyincreasingheadsize,andfocalneurologicsigns.4.Performacarefulphysicalexaminationforskele-talabnormalities,especiallyinthespineandlegs.Thisisparticularlyimportantbeforethechildbe-ginstobearweight.5.Refertheinfanttoappropriatespecialists,asmdi-cated.6.Checktheinfant’sneurodevelopmentalprogressateachvisit.AnticipatoryGuidanceI.Reviewthefamily’spsychologicalsupportandintrafamilialrelationships.2.Advisetheparentstousesunprotection(sun-screen)ontheinfant.Sunexposuredeepenspig-mentinCLS.Althoughthisisusuallyofcosmeticsignificanceonly,melanomaandbasalcellcarci-nomahavebeenreportedinadultswithNF-1(cid:1)213.Ifnecessary,reviewfuturepregnancyplanningforparents.HEALTHSUPERVISIONFROM1TO5YEARS-EARLYCHILDHOODExaminationI.Examinethechildforneurofibromataandnewfreckling(whichcanappearinanyintertriginousarea).AssureparentsthatCLSandfrecklinghaveonlycosmeticsignificance.2.Considertakingphotographstodocumentlesionsizeforfuturereference.3.Evaluatethechild’svision.4.Recommendthatthechildreceiveanophthalmo-logicalexaminationannually.5.Iftherearevisualchanges,persistentheadaches,seizures,amarkedincreaseinheadsize,oraplexiformneuromaofthehead,obtaincomputedtomographyormagneticresonanceimagingofthehead.6.Assessthechild’sspeech.AnticipatoryGuidanceI.Provideanti-pruriticmedicationasnecessary.Pruritismaybefoundwithcutaneousneurofibro-mata.2.Reviewthechild’spreschoolprogram.3.Obtainapsychologicalevaluationofthechildforassessmentoflearningabilities.Thechildmaybenefitfromspecialpreschooleducationpro-gramsandspeechtherapy.4.Referthechildforanaudiogrambeforeheorsheentersapreschoolorschoolprogram.5.Discussindicationsforsurgery,asappropriate.Ifthereisachangeinthesizeofsuperficialneuro-fibromataorevidenceofaspace-occupyinginter-nallesion,referthechildtoanNFclinicorotherHEALTHSUPERVISIONFROM5TO13YEARS-LAThCHILDHOODExaminationI.Examinethechildforskintumorscausingdis-figurementandobtainaconsultationwithaspecialistifsurgeryisdesiredtoimproveappear-anceorfunction.Severecosmeticdisfigurementismoreoftenseeninadultsthaninchildren.2.Evaluatethechildforsignsofpuberty.Prematureonsetofsexualmaturationordelayedpubertymayoccur.Ifsexualprecocityispresent,evaluatethechildforpresenceofopticgliomaorhypotha-lamiclesion.20’(cid:1)3.Checkforsignsoflearningdisabilities,hyperac-tivity,andbehaviorproblems.4.Reviewthechild’ssocialadjustment.AnticipatoryGuidanceI.Reviewthechild’sdevelopmentandappropriate-nessofschoolplacement.2.Referthechildtoaclinicalpsychologistorchildpsychiatristforfurtherevaluationandtherapyasindicated.3.Reviewtheeffectsofpubertyonthedisease.4.Discussthepossibilityofthegrowthofneurofi-bromataduringadolescenceandpregnancy.HEALTHSUPERVISIONFROM13TO21YEARSOROLDER-ADOLESCENCETOEARLYADULTHOODExaminationI.Refertheadolescentforanophthalmologicalex-arninationannually.2.Examinetheadolescentforsignsofpubertyorhypogonadism.3.Performaneurologicalexaminationtocheckfordeepplexiformneurofibromata.4.Obtainasurgicalconsultationwithaspecialistifsignsofpressureondeepstructuresarefound.I.DiscussthegeneticsofNF-1orrefertheadoles-centforgeneticcounseling.2.Discusssexuality.3.Discussbirthcontrol,includingtherisksandbenefitsofbirthcontrolpills,andreproductiveoptions.4.DiscusstheeffectofpregnancyonNF-l,ifappro-priate.WomenwithNF-1mayhavecomplicationsduringpregnancybecauseofenlargementoftheneurofibromata.(cid:1)’245.Reviewtheprenataldiagnosisbycurrentlyavail-ablemolecularDNAstudiesanditsapplicabilitytothepatientwithNF-l,orreferthepatienttoageneticist.6.Facilitatetransfertoadultmedicalcare.COMMI-i-I-EEONGENETICS,1994TO1995MargrettaR.Seashore,MD,ChairpersonSechinCho,MDFranklinDesposito,MDJackSherman,MDRebeccaS.Wappner,MDMiriamG.Wilson,MDby guest on May 2, 2017Downloaded from 372HEALTHSUPERVISIONFORCHILDRENWITHNEUROFIBROMATOSISLIAISONREPRESENTATIVESFelixdelaCruz,MDNationalInstitutesofHealthJamesW.Hanson,MDAmericanCollegeofMedicalGeneticsJaneLin-Fu,MDHealthResourcesandServicesAdministrationPaulG.McDonough,MDAmericanCollegeofObstetriciansandGynecologistsGodfreyOakley,MDCentersforDiseaseControlandPreventionAAPSEcrIoNLIAISONBethA.Pletcher,MDSectiononGeneticsandBirthDefectsACKNOWLEDGMENTSForfurtherinformationpleasecontact:NationalNeurofibroma-tosisFoundation,95PineStreet,16Fuller,NewYork,NY10005;Telephone:1-800-323-7938or(212)344-6633.REFERENCES1.DunnDW.Neurofibromatosisinchildhood.CurrProblPediatr.1987;17:445-4972.HusonSM.Recentdevelopmentsinthediagnosisandmanagementofneurofibromatosis.ArchDisChild.1989;64:745-7493.1-lusonSM,HughesRAC,eds.TheNeurofibromatoses:APathogeneticandClinicalOverview.London,England:ChapmanandHall;19944.ListernickR,CharrowJ.Neurofibromatosistype1inchildhood.IPediatr.1990;116:845-8535.ObringerAC,MeadowsAT,ZackaiEH.Thediagnosisofneurofibro-matosis-linthechildundertheageof6years.AJDC.1989;143:717-7196.RiccardiVM.Type1neurofibromatosisandthepediatricpatient.CurrProblPediatr.1992;22:66-1067.RiccardiVM.Neurofibromatosis:Phenotype,NaturalHistoryandPathogen-esis.2nded.Baltimore,MD:TheJohnsHopkinsUniversityPress;19928.RubensteinAE,KorfBR,eds.Neurofibromatosis:AHandbookforPatients,FamiliesandHealth-careProfessionals.NewYork,NY:ThiemeMedicalPublishers;19909.CroweFW,SchullWJ,NeelJV.AClinical,Pathological,andGeneticStudyofMultipleNeurofibromatosis.Springfield,IL:CharlesCThomas;195610.NationalInstitutesofHealth(NIH)ConsensusDevelopmentConfer-enceStatement:neurofibromatosis.Neurofibromatosis.1988;1:172-17811.HopeDG,MulvihillJJ.Malignancyinneurofibromatosis.AdoNeurol.1981;29:33-5612.EldridgeR,DencklaMB,BienE,etal.NeurofibromatosistypeI(Reck-linghausen’sdisease):neurologicandcognitiveassessmentwithsiblingcontrols.AJDC.1989;143:833-83713.HofmanKJ,HarrisEL,BryanRN,DencklaMB.Neurofibromatosistype1:thecognitivephenotype.IPediatr.1994;124:S1-S814.CareyJC,LaubJM,HallBD.Penetranceandvariabilityinneurofibromatosis:ageneticstudyof60families.BirthDefects:OriginalArticleSeries.1979;15:271-28115.BarkerD,WrightE,NguyenK,etal.GeneforvonRecklinghausenneurofibromatosisisinthepericentricregionofchromosome17.Sci-ence.1987;236:1100-110216.FountainJW,WallaceMR.BreretonAM,etal.PhysicalmappingofthevonRecklinghausenneurofibromatosisregiononchromosome17.AmIHumGenet.1989;44:58-6717.LedbetterDH,RichDC,O’ConnellP,LeppertM,CareyJC.PreciselocalizationofNFlto17q11.2bybalancedtranslocation.AmIHumGenet.1989;44:20-2418.GutmannDH,CollinsPS.TheneurofibromatosistypeIgeneanditsproteinproduct,neurofibromin.Neuron.1993;10:335-34319.HofmanKJ,BoehmCD.Familialneurofibromatosistype1:clinicalexperiencewithDNAtesting.IPediatr.1992;120:394-39820.ListernickR,CharrowJ,GreenwaldMJ,EsterlyNB.Opticgliomasinchildrenwithneurofibromatosistype1.1Pediatr.1989;114:788-79221.KnightWA,MurphyWK,GottliebJA.Neurofibromatosisassociatedwithmalignantneurofibromas.ArchDermatol.1973;107:747-75022.LaueL,ComiteF,HenchK,etal.Precociouspubertyassociatedwithneurofibromatosisandopticgliomas:treatmentwithluteimzinghor-monereleasinghormoneanalogue.AJDC.1985;139:1097-110423.BlicksteinI,LancetM,ShohamZ.Theobstetricperspectiveofneurofi-bromatosis.AmJObstetGynecol.1988;158:385-38824.WeissmanA,JakobiP.ZaidiseI,DruganA.Neurofibromatosisandpregnancy:anupdate.IReprodMed.1993;38:890-896by guest on May 2, 2017Downloaded from  1995;96;368PediatricsCommittee on Genetics, 1994 to 1995Health Supervision for Children With Neurofibromatosis(cid:160)(cid:160) ServicesUpdated Information & /content/96/2/368including high resolution figures, can be found at:Citations /content/96/2/368#related-urlsThis article has been cited by 2 HighWire-hosted articles:Permissions & Licensing /site/misc/Permissions.xhtmlor in its entirety can be found online at: Information about reproducing this article in parts (figures, tables) Reprints /site/misc/reprints.xhtmlInformation about ordering reprints can be found online:Online ISSN: 1098-4275.Copyright © 1995 by the American Academy of Pediatrics. All rights reserved. Print ISSN: 0031-4005. American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois, 60007.has been published continuously since 1948. PEDIATRICS is owned, published, and trademarked by the PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly publication, itby guest on May 2, 2017Downloaded from  1995;96;368PediatricsCommittee on Genetics, 1994 to 1995Health Supervision for Children With Neurofibromatosis(cid:160)(cid:160)(cid:160) /content/96/2/368the World Wide Web at: The online version of this article, along with updated information and services, is located on(cid:160)ISSN: 0031-4005. Online ISSN: 1098-4275.PrintIllinois, 60007. Copyright © 1995 by the American Academy of Pediatrics. All rights reserved. by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village,it has been published continuously since 1948. PEDIATRICS is owned, published, and trademarked PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly publication,by guest on May 2, 2017Downloaded from 